{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T16:59:06Z","timestamp":1775321946619,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ajog.2017.02.029","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T20:32:07Z","timestamp":1487795527000},"page":"53.e1-53.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Assessment of serum HE4 levels throughout the normal menstrual cycle"],"prefix":"10.1016","volume":"217","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5598-5263","authenticated-orcid":false,"given":"Richard G.","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Plante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Hartnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Mitchel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine A.","family":"Raker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Vitek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geralyn","family":"Lambert-Messerlian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2017.02.029_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1515\/CCLM.2011.075","article-title":"The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?","volume":"49","author":"Montagnana","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ajog.2017.02.029_bib2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2017.02.029_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A\u00a0novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2017.02.029_bib4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1159\/000442288","article-title":"CA125 and HE4: measurement tools for ovarian cancer","volume":"81","author":"Zhao","year":"2016","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ajog.2017.02.029_bib5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","article-title":"A\u00a0radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer","volume":"309","author":"Bast","year":"1983","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.02.029_bib6","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/bjc.1984.254","article-title":"Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker","volume":"50","author":"Canney","year":"1984","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2017.02.029_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.humrep.a136832","article-title":"The CA 125 tumour-associated antigen: a review of the literature","volume":"4","author":"Jacobs","year":"1989","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.029_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/172460089801300411","article-title":"CA 125 in benign gynecological conditions","volume":"13","author":"Meden","year":"1998","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.ajog.2017.02.029_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1447-0756.1991.tb00288.x","article-title":"Serial changes of serum CA125 levels during menstrual cycles","volume":"17","author":"Nonogaki","year":"1991","journal-title":"Asia Oceania J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2017.02.029_bib10","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajog.2017.02.029_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajog.2011.12.029","article-title":"Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders","volume":"206","author":"Moore","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.02.029_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.12.028","article-title":"Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age","volume":"206","author":"Moore","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.02.029_bib13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/humrep\/14.2.566","article-title":"Fluctuations in CA 125 and CA 15-3 serum concentrations during spontaneous ovulatory cycles","volume":"14","author":"Bon","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.029_bib14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/1099800411412766","article-title":"A\u00a0comparison of the cyclic variation in serum levels of CA125 across the menstrual cycle using two commercial assays","volume":"14","author":"McLemore","year":"2012","journal-title":"Biol Res Nurs"},{"key":"10.1016\/j.ajog.2017.02.029_bib15","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajog.2017.02.029_bib16","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Hellstrom","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajog.2017.02.029_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13277-010-0049-1","article-title":"Ovarian tumor marker HE4 is differently expressed during the phases of the menstrual cycle in healthy young women","volume":"31","author":"Anastasi","year":"2010","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ajog.2017.02.029_bib18","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ygyno.2012.03.011","article-title":"Serum HE4 concentration is not dependent on menstrual cycle or hormonal treatment among endometriosis patients and healthy premenopausal women","volume":"125","author":"Hallamaa","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2017.02.029_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s13277-011-0256-4","article-title":"Human epididymis protein 4 reference limits and natural variation in a Nordic reference population","volume":"33","author":"Bolstad","year":"2012","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ajog.2017.02.029_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00404-006-0242-z","article-title":"Evaluation of factors that may be responsible for cyclic change of CA125 levels during menstrual cycle","volume":"275","author":"Kafali","year":"2007","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2017.02.029_bib21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000030018","article-title":"Peritoneum and tissues of the female reproductive tract as physiological sources of CA-125","volume":"19","author":"Zeimet","year":"1998","journal-title":"Tumour Biol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817303204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817303204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:15:25Z","timestamp":1757589325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937817303204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0002937817303204"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2017.02.029","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of serum HE4 levels throughout the normal menstrual cycle","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2017.02.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}